Tempus AI Files for IPO

Ticker: TEM · Form: S-1 · Filed: May 20, 2024 · CIK: 1717115

Tempus Ai, Inc. S-1 Filing Summary
FieldDetail
CompanyTempus Ai, Inc. (TEM)
Form TypeS-1
Filed DateMay 20, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$188.0 m, $257.9 m, $320.7 million, $531.8 million, $115.6 million
Sentimentneutral

Sentiment: neutral

Topics: ipo, sec-filing, registration-statement

TL;DR

Tempus AI is going public, get ready for some AI healthcare action.

AI Summary

Tempus AI, Inc. filed an S-1 registration statement on May 20, 2024, to become a publicly traded company. The company, formerly known as Tempus Labs, Inc., is based in Chicago, Illinois, and is led by CEO Eric Lefkofsky. This filing indicates their intent to offer shares to the public, marking a significant step in their corporate lifecycle.

Why It Matters

This S-1 filing signals Tempus AI's move towards becoming a public company, which could provide significant capital for expansion and innovation in the AI and healthcare sectors.

Risk Assessment

Risk Level: medium — As a company going public, Tempus AI faces the inherent risks associated with market volatility, regulatory scrutiny, and the challenges of scaling operations to meet public market expectations.

Key Players & Entities

  • Tempus AI, Inc. (company) — Registrant
  • May 20, 2024 (date) — Filing Date
  • Eric Lefkofsky (person) — CEO, Founder and Chairman
  • Chicago, Illinois (location) — Principal Executive Offices
  • Tempus Labs, Inc. (company) — Former Company Name

FAQ

What is the primary purpose of this S-1 filing?

The S-1 filing is a registration statement required by the SEC for companies intending to offer securities, such as stock, to the public for the first time.

When was this S-1 filing submitted?

The S-1 filing was submitted on May 20, 2024.

Who is the Chief Executive Officer of Tempus AI, Inc.?

Eric Lefkofsky is the Chief Executive Officer, Founder, and Chairman of Tempus AI, Inc.

What is the principal business address of Tempus AI, Inc.?

The principal business address is 600 West Chicago Avenue, Suite 510, Chicago, Illinois 60654.

What was Tempus AI, Inc. formerly known as?

Tempus AI, Inc. was formerly known as Tempus Labs, Inc.

Filing Stats: 4,544 words · 18 min read · ~15 pages · Grade level 14.6 · Accepted 2024-05-20 17:04:38

Key Financial Figures

  • $188.0 m — staff. We generated total revenue of $188.0 million, $257.9 million, $320.7 million a
  • $257.9 m — erated total revenue of $188.0 million, $257.9 million, $320.7 million and $531.8 millio
  • $320.7 million — enue of $188.0 million, $257.9 million, $320.7 million and $531.8 million in the years ended D
  • $531.8 million — ion, $257.9 million, $320.7 million and $531.8 million in the years ended December 31, 2020, 2
  • $115.6 million — 2021, 2022 and 2023, respectively, and $115.6 million and $145.8 million in the three months
  • $145.8 million — 3, respectively, and $115.6 million and $145.8 million in the three months ended March 31, 202
  • $89.5 m — nue generated from COVID-19 testing was $89.5 million, or 47.6% of our total revenue, $
  • $94.7 m — million, or 47.6% of our total revenue, $94.7 million, or 36.7% of our total revenue, $
  • $22.2 m — million, or 36.7% of our total revenue, $22.2 million, or 6.9% of our total revenue, an
  • $2.7 m — lion, or 6.9% of our total revenue, and $2.7 million, or 0.5% of our total revenue for
  • $2.6 m — nue generated from COVID-19 testing was $2.6 million, or 2.3% of our total revenue, an
  • $0 — lion, or 2.3% of our total revenue, and $0 for the three months ended March 31, 20
  • $289.8 million — rter of 2023. We incurred net losses of $289.8 million and $214.1 million in the years ended D
  • $214.1 million — curred net losses of $289.8 million and $214.1 million in the years ended December 31, 2022 an
  • $54.4 million — er 31, 2022 and 2023, respectively, and $54.4 million and $64.7 million in the three months e

Filing Documents

Risk Factors

Risk Factors 28 Special Note Regarding Forward-Looking Statements 104 Market, Industry and Other Data 106

Use of Proceeds

Use of Proceeds 108 Dividend Policy 109 Capitalization 110

Managements Discussion and Analysis of Financial Condition and Results

Managements Discussion and Analysis of Financial Condition and Results of Operations 117

Business

Business 144 Management 213 Page

Executive Compensation

Executive Compensation 222 Certain Relationships and Related Party Transactions 234 Principal Stockholders 239

Description of Capital Stock

Description of Capital Stock 242 Shares Eligible for Future Sale 250 Material U.S. Federal Income Tax Consequences to Non-U.S. Holders of Our Class A Common Stock 254

Underwriting

Underwriting 258 Legal Matters 269 Experts 269 Where You Can Find Additional Information 270 Index to Consolidated Financial Statements F-1 Neither we nor any of the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. Neither we nor any of the underwriters take responsibility for, or can provide any assurance as to the reliability of, any other information that others may give you. We and the underwriters are offering to sell, and seeking offers to buy, shares of our Class A common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our Class A common stock. For investors outside the United States: neither we nor any of the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our Class A common stock and the distribution of this prospectus outside of the United States. i Table of Contents PROSPECTUS SUMMARY This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing in our Class A common stock. You should read this entire prospectus carefully, including the sections titled Risk Factors, Managements Discussion and Analysis of Financial Condition and Results of Operations and our consolidated financial statements and the related notes included elsewhere in this prospectus, b

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.